---
figid: PMC3074466__nihms-275356-f0007
figlink: /pmc/articles/PMC3074466/figure/F7/
number: Figure 7
caption: 'Upper half: Overexpression of IFNα activates myeloid DC (mDC) to increase
  BAFF production. This increased BAFF production further activates mDC and promotes
  increased B cell survival and activation, the latter leading to increased B cell
  responses to endogenous and/or exogenous TLR ligands. Collectively, this results
  in production of IL-6 and other proinflammatory cytokines and culminate in exaggerated
  disease. Lower half: Overexpression of IFNα directly activates both mDC and B cells.
  Such activation does not require BAFF as an intermediary, but a distinct BAFF-driven
  pathway in parallel must be present for exaggerated disease to develop.'
pmcid: PMC3074466
papertitle: B cell- and BAFF-dependence of IFNα-exaggerated disease in SLE-prone NZM
  2328 mice.
reftext: Noam Jacob, et al. J Immunol. ;186(8):4984-4993.
pmc_ranked_result_index: '47293'
pathway_score: 0.926243
filename: nihms-275356-f0007.jpg
figtitle: B cell- and BAFF-dependence of IFNAlpha-exaggerated disease in SLE-prone
  NZM 2328 mice
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3074466__nihms-275356-f0007.html
  '@type': Dataset
  description: 'Upper half: Overexpression of IFNα activates myeloid DC (mDC) to increase
    BAFF production. This increased BAFF production further activates mDC and promotes
    increased B cell survival and activation, the latter leading to increased B cell
    responses to endogenous and/or exogenous TLR ligands. Collectively, this results
    in production of IL-6 and other proinflammatory cytokines and culminate in exaggerated
    disease. Lower half: Overexpression of IFNα directly activates both mDC and B
    cells. Such activation does not require BAFF as an intermediary, but a distinct
    BAFF-driven pathway in parallel must be present for exaggerated disease to develop.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IFNA16
  - IFNA2
  - IFNA1
  - IFNA10
  - IFNA21
  - IFNA5
  - IFNA14
  - CCL22
  - IFNA17
  - TNFSF13B
  - IFNA8
  - KY
  - IFNA13
  - IFNA7
  - IL6
  - IFNA4
  - IFNA6
genes:
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA16
  entrez: '3449'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA2
  entrez: '3440'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA10
  entrez: '3446'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA21
  entrez: '3452'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA5
  entrez: '3442'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA14
  entrez: '3448'
- word: mDC
  symbol: MDC
  source: hgnc_alias_symbol
  hgnc_symbol: CCL22
  entrez: '6367'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA17
  entrez: '3451'
- word: BAFF
  symbol: BAFF
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF13B
  entrez: '10673'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA8
  entrez: '3445'
- word: ky
  symbol: KY
  source: hgnc_symbol
  hgnc_symbol: KY
  entrez: '339855'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA13
  entrez: '3447'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA7
  entrez: '3444'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA4
  entrez: '3441'
- word: IFNa
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA6
  entrez: '3443'
chemicals: []
diseases: []
---
